Table 2 Demographic and clinical characteristics of study participants at baseline
Variablea | Clinic A (n = 71) | Clinic B (n = 176) | Total (N = 247) | p-value |
|---|---|---|---|---|
Age (years), mean ± SD | 48.4 ± 8.4 | 45.9 ± 8.7 | 46.7 ± 8.6 | 0.051 |
Sex, male | 18 (25.4) | 41 (23.3) | 59 (23.9) | 0.865 |
Comorbidity | ||||
 DM only | 0 (0) | 4 (2.3) | 4 (1.6) |  |
 HTN only | 63 (88.7) | 158 (89.8) | 221 (89.5) |  |
 DM and HTN | 8 (11.3) | 14 (7.9) | 22 (8.9) | 0.326 |
Time with NCD (years) | ||||
 0–5 | 43 (60.6) | 124 (70.5) | 167 (67.6) |  |
 6–10 | 20 (28.2) | 4 (2.3) | 24 (9.7) |  |
 > 10 | 3 (4.2) | 3 (1.7) | 6 (2.4) |  < 0.001 |
 Missing | 5 (7.0) | 45 (25.6) | 50 (20.2) |  |
Time with HIV (years) | ||||
 0–5 | 31 (43.7) | 91 (51.7) | 122 (49.4) |  |
 6–10 | 28 (39.4) | 49 (27.8) | 77 (31.7) |  |
 > 10 | 11 (15.5) | 15 (8.5) | 26 (10.5) |  |
 Missing | 1 (1.4) | 21 (11.9) | 22 (8.9) | 0.113 |
Time on ART (years) | ||||
 0–5 | 48 (67.6) | 139 (78.9) | 187 (75.7) |  |
 6–10 | 22 (30.9) | 36 (20.5) | 58 (23.5) |  |
 > 10 | 1 (1.1) | 1 (0.6) | 2 (0.8) | 0.155 |
WHO stage at HIV diagnosis | ||||
 0 | 14 (19.7) | 60 (34.1) | 74 (29.9) |  |
 1 | 21 (29.6) | 53 (30.1) | 74 (29.9) |  |
 2 | 28 (39.5) | 43 (24.4) | 71 (28.7) |  |
 3 | 6 (8.5) | 15 (8.5) | 21 (8.5) |  |
 4 | 2 (2.8) | 5 (2.8) | 7 (2.8) | 0.103 |
CD4 count at HIV diagnosisb | ||||
 < 350 | 40 (56.3) | 89 (50.6) | 129 (52.2) |  |
 ≥ 350 | 25 (35.2) | 42 (23.9) | 67 (27.1) |  |
 Missing | 6 (8.5) | 45 (25.6) | 51 (20.7) | 0.374 |
 Median CD4 count at HIV diagnosis (IQR)b | 294 (121–419) | 249 (150–393) | 261.5 (146–403.5) |  |
 HIV suppression rates | 64 (90.1) | 147 (83.5) | 211 (85.4) |  |
 Missing | 7 (9.9) | 28 (15.9) | 35 (14.2) | 0.627 |